T cell immunosurveillance controls B lymphoma development

OncoImmunology

Volumn 3, Issue 4, 2014, Pages

  Kallies, Axel ^a  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

AID; Bcl6; Germinal center; Immune surveillance; Mutations

Indexed keywords

FAS LIGAND; PROTEIN BCL 6;

ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE ACTIVATION; BCL6 GENE; CANCER CONTROL; CANCER GROWTH; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; GENE MUTATION; GENE OVEREXPRESSION; GERMINAL CENTER; HUMAN; HUMORAL IMMUNITY; IMMUNOREGULATION; IMMUNOSURVEILLANCE; LARGE CELL LYMPHOMA; LYMPHOCYTE DIFFERENTIATION; NONHUMAN; ONCOGENE; T LYMPHOCYTE;

EID: 84902590868     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.4161/onci.28697     Document Type: Article

References (10)

1. Schneider C, Pasqualucci L, Dalla-Favera R. Molecular pathogenesis of diffuse large B-cell lymphoma. Semin Diagn Pathol 2011; 28:167-77; PMID:21842702; http://dx.doi.org/10.1053/j.semdp.2011.04.001
2. Basso K, Dalla-Favera R. Roles of BCL6 in normal and transformed germinal center B cells. Immunol Rev 2012; 247:172-83; PMID:22500840; http://dx.doi.org/10.1111/j.1600-065X.2012.01112.x
3. Nutt SL, Taubenheim N, Hasbold J, Corcoran LM, Hodgkin PD. The genetic network controlling plasma cell differentiation. Semin Immunol 2011; 23:341-9; PMID:21924923; http://dx.doi.org/10.1016/j.smim.2011.08.010
4. Afshar-Sterle S, Zotos D, Bernard NJ, Scherger AK, Rödling L, Alsop AE, Walker J, Masson F, Belz GT, Corcoran LM, et al. Fas ligand-mediated immune surveillance by T cells is essential for the control of spontaneous B cell lymphomas. Nat Med 2014; 20:283-90; PMID:24487434; http://dx.doi.org/10.1038/nm.3442
5. Cattoretti G, Pasqualucci L, Ballon G, Tam W, Nandula SV, Shen Q, Mo T, Murty VV, Dalla-Favera R. Deregulated BCL6 expression recapitulates the pathogenesis of human diffuse large B cell lymphomas in mice. Cancer Cell 2005; 7:445-55; PMID:15894265; http://dx.doi.org/10.1016/j.ccr.2005.03.037
6. Mandelbaum J, Bhagat G, Tang H, Mo T, Brahmachary M, Shen Q, Chadburn A, Rajewsky K, Tarakhovsky A, Pasqualucci L, et al. BLIMP1 is a tumor suppressor gene frequently disrupted in activated B cell-like diffuse large B cell lymphoma. Cancer Cell 2010; 18:568-79; PMID:21156281; http://dx.doi.org/10.1016/j.ccr.2010.10.030
7. Robbiani DF, Nussenzweig MC. Chromosome translocation, B cell lymphoma, and activation-induced cytidine deaminase. Annu Rev Pathol 2013; 8:79-103; PMID:22974238; http://dx.doi.org/10.1146/annurev-pathol-020712-164004
8. Schreiber RD, Old LJ, Smyth MJ. Cancer immunoediting:integrating immunity's roles in cancer suppression and promotion. Science 2011; 331:1565-70; PMID:21436444; http://dx.doi.org/10.1126/science.1203486
9. Pasqualucci L. The genetic basis of diffuse large B-cell lymphoma. Curr Opin Hematol 2013; 20:336-44; PMID:23673341; http://dx.doi.org/10.1097/MOH.0b013e3283623d7f
10. Zhang B, Kracker S, Yasuda T, Casola S, Vanneman M, Hömig-Hölzel C, Wang Z, Derudder E, Li S, Chakraborty T, et al. Immune surveillance and therapy of lymphomas driven by Epstein-Barr virus protein LMP1 in a mouse model. Cell 2012; 148:739-51; PMID:22341446; http://dx.doi.org/10.1016/j.cell.2011.12.031